MarketResearch.com has announced the addition of Business Insights’ new report “The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine.”
Read MoreSeegene introduced Anyplex MDR-TB Screening Test, the first real-time PCR molecular diagnostic capable of simultaneous detection of TB and genetic mutations leading to multi-drug resistant TB (MDR-TB) within four hours.
Read MoreMolecular dermatology research and development innovator DermaGenoma Inc announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive.
Read MoreAspenBio Pharma Inc reported results from the Company’s recently completed AppyScore ELISA-based pivotal clinical trial.
Read MoredeCODE genetics and ARUP Laboratories today announced a partnership through which ARUP will offer deCODE’s DNA-based prostate cancer risk assessment test to its clients nationwide.
Read More